Cite
HARVARD Citation
Tolaney, S. et al. (2021). Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial. Journal of clinical oncology. 39 (21), pp. 2375-2385. [Online].